CAMBRIDGE, Mass., November 7, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today issued a letter to shareholders to give an update on third quarter 2017 and ongoing MyoPro® commercial activities. tor-Letter-3Q17.pdf”>Read more.